Comparing the Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in the Elderly Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.
CONCLUSIONS: Compared to warfarin, NOACs were associated with a significantly lower risk of adverse events, with heterogeneity in treatment effects among different age strata. Overall, the clear safety signal in favor of NOACs over warfarin was evident irrespective of age strata, being most marked in the most elderly.
PMID: 31809694 [PubMed - as supplied by publisher]
Source: Chest - Category: Respiratory Medicine Authors: Chao TF, Chiang CE, Liao JN, Chen TJ, Lip GYH, Chen SA Tags: Chest Source Type: research
More News: Atrial Fibrillation | Bleeding | Coumadin | Databases & Libraries | Health Insurance | Hemorrhagic Stroke | Insurance | Ischemic Stroke | Pradaxa | Respiratory Medicine | Stroke | Study | Taiwan Health | Thrombosis | Vitamin K | Vitamins | Warfarin